Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa
- PMID: 103841
- PMCID: PMC422244
- DOI: 10.1128/iai.22.3.919-925.1978
Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa
Abstract
A high-molecular-weight alkali-labile polysaccharide (PS) isolated from the slime of immunotype 1 Pseudomonas aeruginosa was tested for its ability to protect mice from lethal challenge with the live, homologous organism. Intraperitoneal (i.p.) injection of 10 to 25 microgram of the PS protected 60 to 70% of the mice against challenge with up to 50 50% lethal dose units. Although single immunization of mice with up to 250 microgram of PS effected protective levels of only 70%, two successive immunizations provided 100% protection. Subcutaneous and intravenous immunization with PS also provided protection to i.p. challenges with immunotype 1 P. aeruginosa, but not to i.p. challenge with immunotype 4 P. aeruginosa. Although lipopolysaccharide (LPS) was found to be more immunogenic than PS in out studies, contamination of the alkali-labile PS with LPS did not account for the protection seen. Alkali treatment (0.1 N NaOH, 37 degrees C, 2 h) of the PS destroyed its protective effectiveness, while similarly treated LPS retained its capacity for inducing immunity in mice. Adsorption and passive protection studies with sera raised to either PS or a mixture of PS and LPS indicated that antibody directed to the alkali-labile PS antigen was capable of contributing to the protection of mice against challenge with P. aeruginosa.
Similar articles
-
Induction in mice of cell-mediated immunity to Pseudomonas aeruginosa by high molecular weight polysaccharide and vinblastine.J Immunol. 1982 May;128(5):2121-5. J Immunol. 1982. PMID: 6174622
-
High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.Infect Immun. 1981 Nov;34(2):461-8. doi: 10.1128/iai.34.2.461-468.1981. Infect Immun. 1981. PMID: 6171520 Free PMC article.
-
Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.Infect Immun. 1984 Aug;45(2):309-13. doi: 10.1128/iai.45.2.309-313.1984. Infect Immun. 1984. PMID: 6430805 Free PMC article.
-
Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1.Infect Immun. 1983 Jul;41(1):232-6. doi: 10.1128/iai.41.1.232-236.1983. Infect Immun. 1983. PMID: 6407998 Free PMC article.
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
Cystic fibrosis. Infection and immunity to Pseudomonas.Clin Rev Allergy. 1991 Spring-Summer;9(1-2):47-74. doi: 10.1007/BF02914534. Clin Rev Allergy. 1991. PMID: 1884328 Review.
-
Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244.J Bacteriol. 2010 Nov;192(22):5972-81. doi: 10.1128/JB.00007-10. Epub 2010 Sep 10. J Bacteriol. 2010. PMID: 20833803 Free PMC article.
-
Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.Infect Immun. 1994 Sep;62(9):3608-16. doi: 10.1128/iai.62.9.3608-3616.1994. Infect Immun. 1994. PMID: 7520416 Free PMC article.
-
Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.Infect Immun. 1980 Aug;29(2):489-93. doi: 10.1128/iai.29.2.489-493.1980. Infect Immun. 1980. PMID: 6783532 Free PMC article.
-
Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.Infect Immun. 1981 Aug;33(2):527-32. doi: 10.1128/iai.33.2.527-532.1981. Infect Immun. 1981. PMID: 6792080 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources